The Myocardial Infarction Market is estimated to be valued at US$ 1,816.8 Mn in 2023 and is expected to exhibit a CAGR of 5.9 % over the forecast period from 2021 to 2028, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Myocardial infarction, commonly known as a heart attack, occurs due to reduced blood flow and oxygen delivery to the heart muscle. It damages heart muscles due to blockage in coronary arteries. Some key symptoms include chest pain, shortness of breath, nausea etc. Major treatment types include medication such as antiplatelets, beta-blockers and statins. Other treatment options include procedures such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

Market Dynamics:
The myocardial infarction market is mainly driven by increasing incidence rates of myocardial infarction globally. According to World Health Organization (WHO), cardiovascular diseases (CVDs) kill over 17.9 million people annually, representing 31% of all global deaths. Out of which, myocardial infarction alone is responsible for 8.9 million deaths. Further, expanding geriatric population base is also fueling the market growth. As per UN population data, number of elderly (aged 65 years or over) is projected to grow to 1.5 billion in 2050 from 703 million in 2019, largely driving the need for myocardial infarction treatment. Additionally, ongoing development of advanced medication and treatment devices for myocardial infarction management provides lucrative opportunities for market players over the forecast period.

Read More - https://makuv.com/treatment-strategies-contributing-large-share/